CLBCX
Price
$39.01
Change
-$0.49 (-1.24%)
Updated
Nov 13 closing price
Net Assets
268.67B
TBLTX
Price
$12.89
Change
-$0.14 (-1.07%)
Updated
Nov 13 closing price
Net Assets
70.8M
Interact to see
Advertisement

CLBCX vs TBLTX

Header iconCLBCX vs TBLTX Comparison
Open Charts CLBCX vs TBLTXBanner chart's image
American Funds American Balanced 529C
Price$39.01
Change-$0.49 (-1.24%)
VolumeN/A
Net Assets268.67B
Transamerica Balanced II I3
Price$12.89
Change-$0.14 (-1.07%)
VolumeN/A
Net Assets70.8M
CLBCX vs TBLTX Comparison Chart in %
View a ticker or compare two or three
VS
CLBCX vs. TBLTX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLBCX is a Buy and TBLTX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CLBCX has more cash in the bank: 269B vs. TBLTX (70.8M). TBLTX pays higher dividends than CLBCX: TBLTX (1.85) vs CLBCX (1.04). CLBCX was incepted earlier than TBLTX: CLBCX (24 years) vs TBLTX (8 years). CLBCX (1.35) is less costly to investors than TBLTX (0.62). CLBCX is a more actively managed with annual turnover of: 44.00 vs. TBLTX (38.00). TBLTX has a lower initial minimum investment than CLBCX: TBLTX (0) vs CLBCX (250). CLBCX annual gain was more profitable for investors over the last year : 9.13 vs. TBLTX (-1.66). CLBCX return over 5 years is better than : 37.82 vs. TBLTX (13.65).
CLBCXTBLTXCLBCX / TBLTX
Total Expense Ratio1.350.62218%
Annual Report Gross Expense Ratio1.350.62218%
Fund Existence24 years8 years-
Gain YTD15.46112.952119%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets269B70.8M379,944%
Annual Yield % from dividends1.041.8556%
Returns for 1 year9.13-1.66-550%
Returns for 3 years41.0025.40161%
Returns for 5 years37.8213.65277%
Returns for 10 years76.85N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SYRE23.430.08
+0.34%
Spyre Therapeutics
ATLCP24.18-0.02
-0.08%
Atlanticus Holdings Corp
CVGW22.13-0.13
-0.58%
Calavo Growers
CNM49.11-0.99
-1.98%
Core & Main
UFI3.58-0.12
-3.24%
UNIFI